VACC logo

Vaccitech plc American Depositary Shares


VACC: Vaccitech PLC is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious disease, cancer, and immune tolerance. Its therapeutic programs include VTP-300, in chronic hepatitis B viral (HBV) infection; VTP-200, in high-risk human papillomavirus (HPV); and VTP-850, in prostate cancer and among others. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.


Show VACC Financials

Consumer Interest
SEC Filings

Recent trades of VACC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VACC's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Compositions and methods for vaccination against influenza Dec. 07, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of VACC in WallStreetBets Daily Discussion


Recent insights relating to VACC

CNBC Recommendations

Recent picks made for VACC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VACC

Corporate Flights

Flights by private jets registered to VACC